<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Neurotransmitter release during <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> has been extensively studied and is thought to play a key role in excitotoxic neuronal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The changes in neurotransmitter release and its metabolism may reflect changes in cellular metabolism during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study is to assess alterations in extracellular <z:chebi fb="40" ids="18243">dopamine</z:chebi> and <z:chebi fb="19" ids="28790">serotonin</z:chebi> and their metabolites under varied degrees of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rat striatum to elucidate the pathophysiology of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Twenty rats were used to induce varied forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> by means of bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> along with hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Cerebral blood flow (CBF) in the striatum was measured every 40 minutes by methods of hydrogen clearance and maintained within certain ranges for 6 hours </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="40" ids="18243">Dopamine</z:chebi>, <z:chebi fb="19" ids="28790">serotonin</z:chebi>, and their metabolites were measured every 20 minutes by in vivo microdialysis </plain></SENT>
<SENT sid="6" pm="."><plain>Varying degrees of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> were obtained, ranging from 9.4 to 81.3% of control CBF </plain></SENT>
<SENT sid="7" pm="."><plain>The animals were divided into three groups according to CBF levels measured 20 minutes after the induction of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In the mild <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group (n = 5), CBF ranged from 65 to 88% of baseline levels and resulted in only a slight increase of <z:chebi fb="40" ids="18243">dopamine</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>In the moderate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group (n = 10), CBF ranged from 21 to 48% of baseline levels and resulted in transient increases of <z:chebi fb="40" ids="18243">dopamine</z:chebi> (24-fold) and <z:chebi fb="19" ids="28790">serotonin</z:chebi> (5-fold) </plain></SENT>
<SENT sid="10" pm="."><plain>In the severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group (n = 5), CBF was below 14% of baseline levels and resulted in marked increases in <z:chebi fb="40" ids="18243">dopamine</z:chebi> (462-fold) and <z:chebi fb="19" ids="28790">serotonin</z:chebi> (225-fold) </plain></SENT>
<SENT sid="11" pm="."><plain>These alterations remained elevated for 3 hours.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>